VEINWAY
VeinWay is a medical device firm that develops a catheter for recanalizing chronic venous occlusions due to blockage or disease.
VEINWAY
Social Links:
Industry:
Health Care Medical Medical Device
Founded:
2020-01-01
Address:
Or Yehuda, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.veinway.com
Total Employee:
11+
Status:
Active
Contact:
+972-73-204-0408
Email Addresses:
[email protected]
Technology used in webpage:
Organization Schema Cloudflare Hosting Person Schema
Similar Organizations
FloBio
FloBio develops point-of-care diagnostics for bleeding risk based on real-time blood analysis.
Huihe Healthcare
Huihe Healthcare specializes in the development of medical devices for structural heart disease.
MACH32
MACH32 is a medical device startup that develops innovative solutions for new and longstanding medical problems.
Patternox
Patternox is a medical device firm that develops a scanner for detecting precancerous skin deformations with the help of AI.
PregnanTech
PregnanTech is a health care firm that develops health devices for a safe and non-surgical solution in the prevention of preterm birth.
Pression
Medical device company improving blood flow volume body-wide using smart compression with initial focus on heart failure patients.
Quantitative Radiology Solutions
Quantitative Radiology Solutions offers advanced body-wide quantification of medical images.
Taryag Medical
Taryag Medical is a medical device company that develops and manufactures invasive vascular devices.
Investors List
Jordan Feiger
Jordan Feiger investment in Seed Round - VeinWay
MedTech Innovator
MedTech Innovator investment in Non Equity Assistance - VeinWay
MEDX Xelerator
MEDX Xelerator investment in Pre Seed Round - VeinWay
Official Site Inspections
http://www.veinway.com Semrush global rank: 11.69 M Semrush visits lastest month: 152
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "VeinWay"
Veinway – Venous Recanalization. Controlled
VeinWay’s Traversa is designed as a first-of-its-kind device empowering physicians to cross previously uncrossable veins quickly, safely, and reliably. Traversa’s Benefits. Fast Designed …See details»
VeinWay - Crunchbase Company Profile & Funding
Organization. VeinWay . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. VeinWay is a medical device firm that develops a …See details»
Team - Veinway
Veinway is a member of MEDX Xelerator, a medical device incubator backed by Boston Scientific, Sheba Medical Center, MEDX Ventures Group, Consensus Business Group (CBG), West …See details»
Veinway Company Profile 2024: Valuation, Funding & Investors
Veinway General Information Description. Operator of a pre-clinical medical device company intended to change the paradigm of treating chronic venous disease. The company's platform …See details»
VeinWay - Funding, Financials, Valuation & Investors - Crunchbase
Sep 7, 2023 VeinWay is a medical device firm that develops a catheter for recanalizing chronic venous occlusions due to blockage or disease. Search Crunchbase. ... How much funding has …See details»
VeinWay opens up the path to stop blood clots in
May 23, 2023 VeinWay’s entire existence is to improve access to healthcare for patients suffering from chronic venous disease and to provide Interventional Radiologists with the tools they need to open, treat, and be effective healers …See details»
VeinWay - Products, Competitors, Financials, Employees, …
VeinWay. Frequently Asked Questions (FAQ) When was VeinWay founded? VeinWay was founded in 2020. Where is VeinWay's headquarters? VeinWay's headquarters is located at 8 …See details»
VeinWay’s CEO: “This is a pivotal year for us”. An …
May 29, 2024 With seven compassionate-use cases under its belt and commercialization in view, VeinWay—developer of the Traversa, a tool for crossing tough venous occlusions—is at a crucial point in its evolution. That is …See details»
VeinWay CEO: “This is a pivotal year for us” - Venous …
May 29, 2024 Jordan Pollack. With seven compassionate-use cases under its belt and commercialization in view, VeinWay—developer of the Traversa, a tool for crossing tough venous occlusions—is at a crucial point in its evolution. …See details»
VeinWay - VentureRadar
Similar Companies: Venous Stent BV Netherlands Privately Held Developing the world’s first in length adjustable multi-segmented venous stent. Deep Vein Thrombosis (DVT) affects close to …See details»
VeinWay - Israeli Startup | Startup Nation Finder
May 23, 2023 VeinWay is focused on developing a novel technology for crossing chronically occluded veins. VeinWay's Traversa delivers the first dedicated device designed for venous …See details»
Israeli Startup VeinWay Can Clear Blood Clots
May 25, 2023 VeinWay is an Israeli medtech startup developing new technologies to clear blood clots. The firm has so far raised $2.5 million for the treatment of venous disease. Johns …See details»
Jordan Pollack: Transforming Middle East Healthcare With …
Jun 11, 2024 Innovation meets necessity in the constantly evolving sector of the Middle East’s medical device industry, where Jordan Pollack, CEO of VeinWay Ltd, emerges as a paradigm …See details»
Health Tech: Jordan Pollack on How VeinWay’s Technology Can
Mar 1, 2022 At VeinWay, I have surrounded myself with advisors and partners who believe in the vision and show up every day to help make it a reality. They are reliable, smart, and driven …See details»
VeinWay CEO: “This is a pivotal year for us” - MEDX Xelerator
May 30, 2024 VeinWay CEO: “This is a pivotal year for us” ... International Society of Pelviperineology, the Israeli Society of Pelvic Floor Medicine (and was the secretary of this …See details»
VeinWay Closes SAFE Round and Begins Series A Round of Financing
Sep 19, 2023 VeinWay is a portfolio company of the MedX Xelerator, a medical device incubator backed by Boston Scientific, Sheba Medical Center, and other investors. Advertisement. …See details»
In Venous Thromboembolic Disease, VeinWay Aims for a
Sep 15, 2022 VeinWay finally has an effective and purpose-built solution. Interventional radiologists and vascular surgeons who work in venous disease are the handy “MacGyvers” of …See details»
VeinWay Closes Oversubscribed SAFE Round and Begins Series A …
Or Yehuda, Israel, September 7, 2023 — VeinWay has closed an oversubscribed SAFE round of investment and has opened a series A round. The funds will be used to complete all design …See details»
VeinWay crossing tool sees first-in-human compassionate use for …
Mar 2, 2023 In a first-in-human, compassionate-use case approved by the US Food and Drug Administration (FDA), University of Michigan Health (Ann Arbor, USA) interventional …See details»
First-in-Human Compassionate use of Veinway’s Traversa
Mar 2, 2023 Ann Arbor, Michigan and Or Yehuda, Israel, March 2, 2023 — In a first-in-human, compassionate use case approved by the U.S. Food and Drug Administration, University of …See details»